Abstract
This report examines international trade and worldwide market trends pertaining to erythromycin and its derivatives. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on erythromycin and its derivatives export/import operations segmented by country and region. The report covers the 2002-2006 period, with more emphasis on foreign trade in 2006.
The report provides the following analytical materials on the erythromycin and its derivatives: general description, international trade dynamics (2002-2006), exports/imports (2006) broken down by country, major suppliers and consumers, average price, international trade prospects, world market development forecast for 2007-2011.
International trade operations in more than 125 countries are highlighted through 150 tables and diagrams.
Table of Contents
1. Resume: the world trade in erythromycin and its derivatives
- 1.1. Erythromycin and its derivatives: uses and properties
- 1.2. Erythromycin and its derivatives: international trade in 2002-2006
2. Erythromycin and its derivatives exports in 2006
- 2.1. Executive summary
- 2.1.1. Erythromycin and its derivatives exports by country (2006)
- 2.1.2. Major suppliers (2006)
- 2.2. Erythromycin and its derivatives exports segmented by region and
country (2006
- 2.2.1. Europe
- 2.2.2. Asia and Middle East
- 2.2.3. North America
- 2.2.4. Latin America
- 2.2.5. Africa
- 2.2.6. Oceania
3. Erythromycin and its derivatives imports in 2006
- 3.1. Executive summary
- 3.1.1. Erythromycin and its derivatives imports by country (2006)
- 3.1.2. Key consumers (2006)
- 3.2. Erythromycin and its derivatives imports data broken down by region
and country (2006)
- 3.2.1. Europe
- 3.2.2. Asia and Middle East
- 3.2.3. North America
- 3.2.4. Latin America
- 3.2.5. Africa
- 3.2.6. Oceania
